1 / 16

Mark Connolly Global Market Access Solutions, Switzerland University of Groningen, Netherlands, doctoral candidate

IMPLEMENTATION OF NATIONAL DYSPEPSIA GUIDELINES TO REDUCE PRESCRIBING AND RETURN PATIENTS TO SELF CARE: RESULTS FROM prospective EDUCATIONAL INTERVENTION AND CLINICAL AUDIT & 2 1/2 year follow-up IN ENGLAND . Mark Connolly Global Market Access Solutions, Switzerland

iain
Télécharger la présentation

Mark Connolly Global Market Access Solutions, Switzerland University of Groningen, Netherlands, doctoral candidate

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IMPLEMENTATION OF NATIONAL DYSPEPSIA GUIDELINES TO REDUCE PRESCRIBING AND RETURN PATIENTS TO SELF CARE: RESULTS FROM prospective EDUCATIONAL INTERVENTION AND CLINICAL AUDIT & 2 1/2 year follow-up IN ENGLAND Mark Connolly Global Market Access Solutions, Switzerland University of Groningen, Netherlands, doctoral candidate Study sponsor: Reckitt Benckiser manufacturers of Gaviscon Advance

  2. Background to Study • PPIs are one of the most widely prescribed products on the NHS, although overall costs have been falling since the introduction of generics • PPI Rx volumes continue to increase* • NICE Dyspepsia guidelines suggest (NICE Dyspepsia 2004) • Use empirical PPI for uninvestigated dyspepsia without ALARM symptoms • Reviewed patients with prolonged symptoms annually • Importance of self-care and the role of alginates in the management of NUD and GORD • Encourage step down or step off treatment • A return to self-care with alginates or antacids * NHS, Business Service Authority, Sept 2008

  3. Background to study • NICE guidelines are not explicit regarding the use of an antacid / alginate for step-down and step-off (NICE Dyspepsia Guidelines 2004). • Studies have demonstrated that PPI step-down management is cost-effective (Inadomi, 2003) • Patients can be successfully stepped down and stepped off PPI using educational interventions in combination with alginate (Evans, 2007) • We report here the long-term follow-up to the original study reported by Evans et al. 2007 Inadomi, The Amer J of Gastro 2003;98:1940-1944. Evans, Br. J. Healthcare management 2007; 13:425-430.

  4. Objective • To evaluate the long-term effectiveness of an educational strategy aligned with UK NICE Dyspepsia guidance of “Step Therapy” and returning patients to self care • Step down • Step off

  5. Original study design (Evans, 2007) • Study conducted in Wandsworth PCT involving 9 of 56 GPs practices representing 53,000 patients • Patients on PPIs for >2 months were identified and invited to nurse-led clinic • Educational and treatment intervention • Participants were provided information on causes of dyspepsia and heartburn • Lifestyle advice and alternative treatment options • Participants offered opportunity, depending on their suitability, to lower PPI dose in combination with alginate (Step-down) or discontinue PPI and treat with alginate (step-off)

  6. Original study design (Evans, 2007) • Patients with H.Pylori infection, duodenal or gastric ulcer, grade 3 or 4 oesophagitis, history of oesophageal varices, terminal condition or chronic illness and age <18 or >90 were excluded from participating • Duration of follow-up in original audit was 22 weeks • Study protocol approved by local ethics committee

  7. Initial findings (Evans, 2007) From 9 clinics = Reaudit cohort derived from those agreeing to step therapy

  8. Reaudit protocol • Reaudit conducted between Jan - Feb 2008  • 2.5 years after original audit • 5 of 9 original centres agreed to participate in the reaudit (2 centres moved, 1 centre new manager, 1 lost audit records) • Participating centres based on ability to arrange clinic visit and retention of original audit data • Data collection: Patient consultation and review of historical patient notes since therapy switch • Audit was conducted by nurse advisor

  9. REAUDIT RESULTS

  10. Demographics

  11. Reaudit- Success by therapy change † Newcombe, RG. Statistics in Medicine, 17, 857-872 (1998).

  12. Reaudit : Patients remaining on intervention by surgery † 65 patients enrolled at 4 missing sites

  13. Reaudit- Success by therapy change † Test of single proportion considers 0.5 likelihood of success at 2.5 years. Previous studies have shown persistence on PPI around 27% (van Soest et al. Aliment Pharmacol Ther 2006; 24, 377–385.

  14. Conclusions • Results suggest that an educational intervention in combination with alginate treatment can reduce PPI prescribing • Unable to distinguish whether the educational or alginate component is responsible for the sustained response at 2.5 years • These results fill a gap in the knowledge about how to implement NICE Dyspepsia guidelines

  15. Future work: • Expand the reaudit to include additional centres • Similar audit was conducted in Scotland so will be important to review sustained response of educational intervention • Consider the cost-effectiveness of the educational intervention

  16. Contact information: Mark Connolly Global Market Access Solutions ManagingDirector mark@gmasoln.com

More Related